Systematic evaluation and re-evaluation of buyang huanwu decoction in treating ischemic stroke
Authors:
Open Access
- 19 July 2022
- journal article
- research article
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 70, 102860
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81874416)
- Hunan University of Chinese Medicine
This publication has 10 references indexed in Scilit:
- Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019The Lancet Neurology, 2021
- Network pharmacology‑based prediction of the active compounds and mechanism of Buyang Huanwu Decoction for ischemic strokeExperimental and Therapeutic Medicine, 2021
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsBMJ, 2021
- Effect of Buyang Huanwu decoction for the rehabilitation of ischemic stroke patients: a meta-analysis of randomized controlled trialsHealth and Quality of Life Outcomes, 2021
- Heart Disease and Stroke Statistics—2021 UpdateCirculation, 2021
- Ischemic Stroke in Young AdultsContinuum, 2020
- Effect of Tongqiao Huoxue Decoction Combined with Western Medicine on Ischemic Stroke: A Systematic ReviewEvidence-Based Complementary and Alternative Medicine, 2020
- Combined proteomic and metabolomic analyses of cerebrospinal fluid from mice with ischemic stroke reveals the effects of a Buyang Huanwu decoction in neurodegenerative diseasePLOS ONE, 2019
- Pharmacologic evidence for role of endothelial nitric oxide synthase in neuroprotective mechanism of ischemic postconditioning in miceJournal of Surgical Research, 2014
- Clinical Efficacy and Safety of Buyang Huanwu Decoction for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of 19 Randomized Controlled TrialsEvidence-Based Complementary and Alternative Medicine, 2012